Oxidation Systems
PRODUCTS
-
The AMP2085E-1LC is a compact, rack-mounted solid-state high-power amplifier tailored for diverse applications including EMI/RFI, lab work, and communications.
-
Elevate your RF applications with the Empower RF Model 2247, a cutting-edge amplifier system designed to deliver up to 30kW peak pulsed output power.
-
Anritsu's Capsule Pharmaceutical Checkweigher is the best weighing solution for a variety of capsules, where slight variances in active pharmaceutical ingredients can have a large impact on efficacy. It's equipped with Anritsu's force balance load cell that provides weight accuracy of +/- 0.5 mg. Each capsule is individually weighed, monitored, and tracked. The handling system is designed to minimize static electricity and vibration generated from the drop of the capsule from the magazine to the weigh cell. The rejection mechanism includes three gates and a confirmation sensor to make sure that capsules with incorrect weight are removed from the production flow. Our capsule checkweighers are available in three models with 10, 20, or 30 lanes, and a maximum inspection capacity of 230,000 capsules/h.
-
Enabling organizations of all sizes to transform their business through better use of technology.
-
The AMP2070D-LC is a small form factor Solid State High Power Amplifier designed for EMI/RFI, lab, CW/Pulse and all communication applications.
WHITE PAPERS AND CASE STUDIES
-
Generate High Quality Data And Execute Full Factorial Design Of Experiments
Learn how a bioprocessing company supplemented their in-house bioreactor capacity and performed large-scale DOE studies using a cloud bioreactor facility.
-
Early-Stage Development In Rare Pediatric Oncology
Learn about the strategic approach a biotechnology company utilized to address significant hurdles in launching a Phase 1 clinical trial for a novel therapy targeting a rare pediatric cancer.
-
Commercializing Rare Disease Treatment With Near Real-Time Alerts
How did Quest help a leading pharmaceutical company overcome the data latency challenges associated with traditional EHR when recruiting eligible patients for a rare blood disorder drug?
-
Seizing Market Share Pre-Patent Expiry: The Evolution Of A CDMO Partnership In Navigating A Paragraph IV ANDA Submission
The dynamic pharmaceutical landscape demands agility and strategic foresight. Explore how leveraging a key partnership helped to overcome a looming patent expiry for a second-generation acne medication.
-
Measuring Laser Output In Medical Equipment Manufacturing For FDA Approval
With expertise in power and energy measurement for lasers, see why Gentec-EO is the go-to choice for medical manufacturers in need of accurate and reliable laser beam measurement solutions.
-
Large-Scale, 24/7 Mobile Quality Monitoring And Service Level Verification
Learn how CERN, the European Organization for Nuclear Research, created a reliable, cost-efficient, and fully compliant monitoring system for SLA verification with Android Probe and MNT solutions.
-
Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study
Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
-
BioIVT Collaborates With IDBS To Deploy IDBS E-WorkBook And Reduce Study Cycle Times
Learn about a collaboration that has enabled BioIVT to enhance efficiency and responsiveness to its biopharmaceutical clients.
-
Trial Rescue: Leadership Approach To Propel Clinical Development
Learn how Halloran's assistance was able to improve a rare disease biotechnology company’s development and operations, communication workflow, and avoid the delay of a gene therapy trial.
-
Meeting 100% Recruitment 7 Months Ahead Of Schedule
Uncover the detailed outcomes of this extensive Phase 3 clinical trial on a new biosimilar for non-small cell lung cancer.
-
Breaking Barriers In Malaria Prevention With A Mobile Cleanroom
The delivery of this mobile cGMP cleanroom facility to ACT showcases Germfree’s commitment to providing innovative solutions that meet clients' unique needs and contribute to advancing healthcare.
-
How Waterloo Harnessed Qatium's Digital Platform
Read about the City of Waterloo, that needed an intuitive, low-cost tool to empower operators without requiring specialized technical expertise.
NEWS
-
U.S. Department Of Energy Announces $6.9M In Projects To Support Effective Community Waste-To-Energy Strategies For Local Transportation Needs1/7/2025
The U.S. Department of Energy's (DOE) Bioenergy Technologies Office (BETO) and Vehicle Technologies Office (VTO) announced $6.9M in funding for nine projects to support local waste-to-energy management solutions for transportation energy needs.
-
AEON Biopharma Appoints Industry Veteran Rob Bancroft As Chief Executive Officer4/21/2025
AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications, announced today the appointment of Rob Bancroft as President and Chief Executive Officer, effective April 29, 2025. Mr. Bancroft will also join AEON’s Board of Directors.
-
The Persistence Of PFAS - IDTechEx Covers Growing PFAS Regulations4/24/2025
Per- and polyfluoroalkyl substances (PFAS) are a broad group of chemicals that includes both polymers and non-polymers used in many applications, from transport to consumer products.
-
Shell Expands Gulf Of America Leadership Position With Dover Development4/8/2025
Shell Offshore Inc. (Shell), a subsidiary of Shell plc, today announced the start of production at Dover, the second subsea tieback connecting new wells to the existing infrastructure of the Shell-operated Appomattox production hub in the Gulf of America.
-
Masdar And Iberdrola Announce €5.2B UK Offshore Wind Deal And Full Energization Of 476MW German Offshore Wind Farm7/10/2025
Masdar, a global clean energy leader, and Iberdrola, one of the world’s largest energy companies, have reached two major milestones with a €5.2B co-investment in the UK’s East Anglia THREE offshore wind farm – the largest offshore wind transaction of the decade – and the full energization of their 476MW Baltic Eagle project in Germany.
ABOUT
Oxidation Systems
Waste treatment, ground water remediation and food processing are some of the areas that heavily rely on oxidation systems. Ozone generators, hydrogen peroxide and potassium permanganate are some of the oxidation systems that are important in different oxidation processes. The acquisition of these oxidation systems can be easily done through specialized dealers. It is advantageous to deal through these dealers since they have vast knowledge of what are essential for different processes. Some of these dealers design sell and in certain instances lease these systems. Their experience with advanced oxidation systems, ozone and potassium permanganate makes them the best people to use when such and related concerns arise.
There is no doubt about the transformation that the chemical oxidation technologies have taken. Specialists in the oxidation field work hand in hand with the interested parties in solving all their oxidation related needs. This sequential process begins with the selection of the appropriate oxidation need. Once a technology is selected, they work with the client step by step in designing the system that is suited to one’s application. Other than the identification and assembly, they will provide assembly and maintenance services.
There are certain elements of oxidation systems that one should always know when dealing with these systems. Injection trailers, metering systems and pilot testing systems are some of the things that might be relevant for different oxidation system types and scales. For instance, one involved in ozone oxidation need to be familiar with ozone generators and ozone pilot testing systems.
Like any other process, oxidation need ought to be measured by considering the aspects of benefits and cost. This calls for meticulous review of the energy and chemical costs as well as the by-products. Many tend to forget about the by-products during the initial planning phase until when they have to disinfect them.